HMOX1 and hematologic disorder: The findings of the present study suggested that the donor HO-1 rs2071746 A/A or A/T genotype in the promoter region, which is expected to be highly inducible by HO-1, may improve survival outcomes in patients with high-risk hematologic malignancies who are undergoing unrelated BMT.